BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7174152)

  • 1. Explanation of the biologically implausible correlation between distribution volume and total body clearance in an open two-compartment model.
    Schaumann W; Kaufmann B
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):508-10. PubMed ID: 7174152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical comparison between volume of distribution (V) and volume of distribution at steady-state (Vss) utilizing model-independent approach.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 Mar; 25(2):99-101. PubMed ID: 14872558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of age on the pharmacokinetic parameters of digoxin].
    Korkushko OV; Orlov PA; Bezverkhaia IS; Belyĭ AA
    Farmakol Toksikol; 1984; 47(3):101-4. PubMed ID: 6734802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of digoxin in low-birth-weight infants.
    Collins-Nakai RL; Schiff D; Ng PK
    Dev Pharmacol Ther; 1982; 5(1-2):86-97. PubMed ID: 7151640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin pharmacokinetics in premature infants.
    Hastreiter AR; Simonton RL; van der Horst RL; Benawra R; Mangurten H; Lam G; Chiou WL
    Pediatr Pharmacol (New York); 1982; 2(1):23-31. PubMed ID: 7110753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin disposition kinetics in dogs before and during azotemia.
    Gierke KD; Perrier D; Mayersohn M; Marcus FI
    J Pharmacol Exp Ther; 1978 May; 205(2):459-64. PubMed ID: 641840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-compartment model for digoxin disposition in dogs.
    Kalman SM; Güllner HG; Gibson TA; Kuhn GS; Stinson EB; Miller R; Halpern J
    Arzneimittelforschung; 1980; 30(6):943-5. PubMed ID: 7191268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical analysis of the discrepancy between V(beta) and V(ss) for drugs exhibiting different two-compartment disposition profiles.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2005 Mar; 26(2):51-8. PubMed ID: 15614832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrarenal clearance, distribution volume, and elimination rate of digoxin and metildigoxin in anuric patients.
    Twittenhoff WD; Strauch M; Kütemeyer M; Koch K; Schaumann W
    Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):405-8. PubMed ID: 7298247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urea distribution kinetics analyzed by simultaneous injection of urea and inulin: demonstration that transcapillary exchange is rate limiting.
    Bowsher DJ; Avram MJ; Frederiksen MC; Asada A; Atkinson AJ
    J Pharmacol Exp Ther; 1984 Aug; 230(2):269-74. PubMed ID: 6747836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parabolic quantitative structure-activity relationships and photodynamic therapy: application of a three-compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheophorbide derivatives used as photosensitizers for photodynamic therapy.
    Potter WR; Henderson BW; Bellnier DA; Pandey RK; Vaughan LA; Weishaupt KR; Dougherty TJ
    Photochem Photobiol; 1999 Nov; 70(5):781-8. PubMed ID: 10568170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological hyperinsulinemia has no detectable effect on access of macromolecules to insulin-sensitive tissues in healthy humans.
    Weinhandl H; Pachler C; Mader JK; Ikeoka D; Mautner A; Falk A; Suppan M; Pieber TR; Ellmerer M
    Diabetes; 2007 Sep; 56(9):2213-7. PubMed ID: 17601990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume kinetic analysis of fluid shifts accompanying intravenous infusions of glucose solution.
    Hahn RG; Edsberg L; Sjöstrand F
    Cell Biochem Biophys; 2003; 39(3):211-22. PubMed ID: 14716077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonidine disposition in children; a population analysis.
    Potts AL; Larsson P; Eksborg S; Warman G; Lönnqvist PA; Anderson BJ
    Paediatr Anaesth; 2007 Oct; 17(10):924-33. PubMed ID: 17767627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of ratios of different volumes of distribution in pharmacokinetics.
    Wagner JG
    Biopharm Drug Dispos; 1983; 4(3):263-70. PubMed ID: 6626701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine disposition in children: a population analysis.
    Potts AL; Warman GR; Anderson BJ
    Paediatr Anaesth; 2008 Aug; 18(8):722-30. PubMed ID: 18613931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of the steady-state volume of distribution for digoxin: a comparison of model-independent methods with a two-compartment model in healthy volunteers.
    De Vito JM; Crass RE; Blum RA; Pleasants RA; Schentag JJ
    Drug Intell Clin Pharm; 1985 Nov; 19(11):837-9. PubMed ID: 4064918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration.
    Leypoldt JK
    Semin Dial; 2005; 18(5):401-8. PubMed ID: 16191181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model-independent definition of the initial volume of distribution of drugs in the body.
    Piotrovskii VK
    Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):403-7. PubMed ID: 3759276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.